MNPR
Monopar Therapeutics Inc.$107.80+8.01 (+8.03%)Prev Close$99.79·MCap$700.1M·P/E—·Vol148.9K·Yield—
▲
Buys (12M)
1
$104.9K
▼
Sells (12M)
5
$1.01M
◆
Net Activity
Net Seller
$900.3K
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Monopar Therapeutics Inc. (MNPR) has been dominated by selling, with 1 insider purchase totaling $104.9K and 5 insider sales totaling $1.01M. The most recent insider transaction was by Cittadine Andrew (Chief Operating Officer), who sold $123.4K worth of shares on Dec 31, 2025. Monopar Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $700.1M.
MNPR Insider Trading Activity
MNPR Insider Buying Activity
The following table shows recent insider purchases of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.
MNPR Insider Selling Activity
The following table shows recent insider sales of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.